Form 4: Oric Pharmaceuticals Director Exercises Stock Options, Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Lori Anne Kunkel, a director at Oric Pharmaceuticals, executed stock options at prices of $3.75 and $6.33, altering her holdings in the company's common stock.
Summary
- On March 3, 2025, Lori Anne Kunkel, a director of Oric Pharmaceuticals, exercised stock options.
- She acquired 27,666 shares of common stock at $3.75 per share and 20,500 shares at $6.33 per share.
- Following these transactions, Kunkel directly owns 68,666 shares of Oric Pharmaceuticals' common stock.
- The exercised options had expiration dates in 2032 and 2033.
- Some of the options vested monthly after June 17, 2022.
Sentiment
Score: 5
Explanation: This is a neutral event. It's a routine disclosure of stock option exercises by a company director. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
Form 4 filings are standard disclosures required by the SEC when insiders, like directors and officers, trade in their company's stock. This provides transparency to the market regarding the actions of those with privileged information.
Stakeholder Impact
- Shareholders are informed about changes in beneficial ownership by a company director.
- The market receives transparency regarding insider transactions.
Key Dates
| Date | Description |
|---|---|
| June 17, 2022 | Date from which some stock options began vesting monthly. |
| June 17, 2023 | Date on which 20,500 shares subject to the option shall vest. |
| June 11, 2024 | Expiration date of some stock options. |
| March 3, 2025 | Date of the stock option exercise. |
| March 4, 2025 | Date of signature on the Form 4 filing. |
| June 16, 2032 | Expiration date of some stock options. |
| June 13, 2033 | Expiration date of some stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.